SolveBio Revenue and Competitors
Estimated Revenue & Valuation
- SolveBio's estimated annual revenue is currently $210k per year.
- SolveBio's estimated revenue per employee is $70,000
Employee Data
- SolveBio has 3 Employees.
- SolveBio grew their employee count by -75% last year.
SolveBio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, CEO | Reveal Email/Phone |
SolveBio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.8M | 62 | -30% | N/A | N/A |
#2 | $18.8M | 134 | 11% | $71.6M | N/A |
#3 | $1.3M | 16 | -30% | N/A | N/A |
#4 | $3.2M | 30 | -6% | $8.7M | N/A |
#5 | $1.3M | 15 | 7% | N/A | N/A |
#6 | $1.4M | 17 | 13% | N/A | N/A |
#7 | $7.3M | 58 | 5% | N/A | N/A |
#8 | $8.4M | 67 | N/A | N/A | N/A |
#9 | $14.7M | 105 | 8% | N/A | N/A |
#10 | $6.4M | 51 | 11% | N/A | N/A |
What Is SolveBio?
SolveBio is the industry leader in advanced precision medicine data analytics. Its award-winning technology platform enables biopharma customers to lower trial risk, create more effective therapeutics, and compress the time scale of clinical development. The core of SolveBio's platform is technology to connect genomic data that comes from a rapidly compounding complex landscape of vendors, studies, and patients. SolveBio is based in New York and has raised capital from Andreessen Horowitz, Max Levchin, Faridan Ventures, Flatiron Health cofounders Nat Turner and Zach Weinberg, and other leading technology and life sciences investors. SolveBio's advisory board is made up of George Church, Joel Dudley, Yaniv Erlich, and Stephen Wolfram.
keywords:N/A
N/A
Total Funding
3
Number of Employees
$210k
Revenue (est)
-75%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.3M | 3 | 0% | N/A |
#2 | $0M | 3 | -25% | $16.2M |
#3 | $0.2M | 3 | 0% | N/A |
#4 | $0M | 3 | 0% | $9M |
#5 | $0.2M | 3 | N/A | N/A |